Filipa de Aragão

5PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyHaematologyBehavioural epidemiologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 14, 2026
Impact on health outcomes of treating all eligible large B-cell lymphoma patients with axicabtagene ciloleucel in Portugal - A modeling approach.

|Jul 17, 2026
Impact of screening all high-risk patients at hospital admission for methicillin-resistant Staphylococcus aureus in Spain: a cost-consequence analysis.

|Feb 16, 2022
Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the US.

John Fanikos, Joshua N Goldstein, Belinda Lovelace

|Aug 19, 2021
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort.

Ramón Teira, Helena Diaz-Cuervo, Filipa Aragão

|Apr 08, 2021
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.

Ramón Teira, Helena Diaz-Cuervo, Filipa Aragão

Pageof 1

Frequent Collaborators

1 joint publications

Alberto Romero

1 joint publications

Juan Berenguer

1 joint publications

Marta Montero

1 joint publications

John Fanikos